Review paper
Safety of vedolizumab in liver transplant recipients: A systematic review
Volume: 7, Issue: 7, Pages: 875 - 880
Published: Aug 1, 2019
Abstract
Background The management of inflammatory bowel disease in patients who have previously undergone liver transplantation can be a clinical challenge. There are serious concerns among physicians regarding the use of biologics for treating such immuno‐compromised patients. Objective We performed a systematic review on vedolizumab therapy in transplant recipients to assess its safety. Methods PubMed/Embase/Scopus were searched up to November 2018 to...
Paper Details
Title
Safety of vedolizumab in liver transplant recipients: A systematic review
Published Date
Aug 1, 2019
Volume
7
Issue
7
Pages
875 - 880
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History